Cyprotex US LLC
Framingham, MA Cyprotex US LLC
- UEI
- YNGLSAF57T14
- CAGE
- 47UC6
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 200 Staples Dr, Framingham, MA 01702, USA
- Website
- evotec.com
- Founded
- 1993
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398 - purchase of development of a human neural network formation new approach method for the evaluation of… | Food and Drug Administration | $70,500 | |
| Testing of compounds in human neurite outgrowth assay (adme-TOX services) | Office of Research and Development | $50,000 | |
| High throughput toxicokinetics (httk) - task order #7 | Interior Business Center | $451,818 | |
| EPA -toxicokinetic testing | Interior Business Center | $44,744 | |
| EPA -toxicokinetic testing | Interior Business Center | $362,208 |
About Cyprotex US LLC
Cyprotex US LLC is a foreign-owned, for-profit contract research organization specializing in predictive toxicology, absorption, distribution, metabolism, and excretion (ADME) research, and in vitro toxicology testing. Headquartered in Framingham, Massachusetts, the company provides sophisticated scientific services to federal agencies, primarily focusing on high-throughput toxicokinetics (HTTK) and advanced compound testing. Cyprotex offers specialized laboratory services that help government agencies assess the potential human health and environmental impacts of various chemical compounds through comprehensive in vitro testing methodologies.
The company has consistently provided complex scientific testing services across multiple federal agencies, primarily the Environmental Protection Agency (EPA), National Institutes of Health (NIH), National Cancer Institute (NCI), and National Center for Advancing Translational Sciences (NCATS). Its contract awards encompass a wide range of specialized testing services, including cytochrome P450 (CYP) inhibition assays, network formation assays, Caco-2 permeability assessments, ADME screening, toxicokinetic testing, and investigational drug testing. These services support critical research objectives in chemical risk assessment, drug development, and understanding potential health impacts of various compounds. None of Cyprotex's federal contract awards have utilized small business set-aside provisions, indicating the company competes for contracts based on its specialized scientific capabilities.
Cyprotex holds a significant $13 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with the EPA's Office of Research and Development, awarded in May 2020 with a five-year performance period. This IDIQ contract specifically supports the EPA's High Throughput Toxicokinetics (HTTK) program, enabling the agency to rapidly and cost-effectively generate toxicokinetic data on hundreds of industrial chemicals and environmental contaminants. Under this contract, Cyprotex has already received multiple firm-fixed-price delivery orders totaling over $3.5 million for toxicokinetic testing services. The contract allows the EPA to efficiently obtain specialized testing services to advance its mission of protecting human health and the environment, with task orders spanning comprehensive in vitro assay testing to evaluate chemical absorption, distribution, metabolism, and potential ecological impacts.
Quick answers
What is Cyprotex US LLC's UEI?
Cyprotex US LLC's Unique Entity ID (UEI) in SAM.gov is YNGLSAF57T14.
What is Cyprotex US LLC's CAGE code?
Cyprotex US LLC's CAGE code is 47UC6.
What is Cyprotex US LLC's primary NAICS code?
Cyprotex US LLC's primary NAICS code is 541380 (Testing Laboratories and Services).
Where is Cyprotex US LLC located?
Cyprotex US LLC's physical address in SAM.gov is 200 Staples Dr, Framingham, MA 01702, USA.
Is Cyprotex US LLC registered in SAM.gov?
Yes. Cyprotex US LLC's SAM.gov registration is active through May 27, 2027.
What is Cyprotex US LLC's most recent federal award?
Cyprotex US LLC's most recent federal contract award is EO 14398 - purchase of development of a human neural network formation new approach method for the evaluation of… (75F40126P00176), from Food and Drug Administration, on September 1, 2026.
On GovTribe
See Cyprotex US LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors